3 Game-Changing Stocks to Buy and Hold for the Next 20 Years
These companies are likely to be a lot bigger in 2040 -- and make patient investors a ton of money along the way.
If You Invested $10,000 in Livongo Health's IPO, This Is How Much Money You'd Have Now
The digital health stock has been a big winner.
3 Top Coronavirus Stocks to Buy in October
Their coronavirus programs are only part of the attraction for these stocks.
Where Will Moderna Be in 10 Years?
Probably a lot bigger than it is now.
Better Coronavirus Stock: Johnson & Johnson vs. Novavax
These COVID-19 vaccine leaders offer very different risk-reward propositions.
How Many Small-Cap Stocks Are There?
The number changes quickly.
Why Precigen Stock Is Skyrocketing Today
A big partner is increasing its stake in the biopharmaceutical company.
Is BioNTech a Better Coronavirus Stock to Buy Than Its Big Partner Pfizer?
Here's how the two COVID-19 vaccine partners stack up against each other.
Investing $1,000 in These 3 Stocks Would Be a Really Smart Move Right Now
These stocks are in great shape to deliver strong growth over the long run.
Is This Sizzling IPO Stock Getting Too Hot to Handle?
AmWell is riding high after its IPO last month. Can it keep the momentum going?
Why Cardiff Oncology Stock Skyrocketed Today
An analyst's bullish outlook sent the biotech stock soaring.
Why Aphria, Curaleaf, and Several Other Cannabis Stocks Are Flying Higher Today
Investors appear to be increasingly optimistic about the prospects for marijuana legalization in the U.S. after two developments on Wednesday.
3 Popular Robinhood Stocks That Could Realistically Double Within 1 Year
Here's what it would take.
3 Safe Stocks to Buy in a Not-So-Safe Market
These stocks are well-positioned whether turbulent times come or not.
Why Sorrento Therapeutics Stock Jumped Today
The biotech provided two encouraging updates.
Why GrowGeneration Stock Is Jumping Today
A short squeeze just might be under way.
3 Reasons to Buy the Most Popular Coronavirus Stock on Robinhood
The stock might not be a surprise. But at least one of the reasons to buy it probably will be.
7 Million More Reasons to Stay Away From Aurora Cannabis Stock
Actually, it's closer to 7.4 million reasons.
AstraZeneca's Coronavirus Vaccine Is Already Being Reviewed for Approval in Canada and Europe. Why Not in the U.S.?
This one-time Operation Warp Speed favorite isn't even moving at a snail's speed in America.
Is Inovio a Bad-News Buy?
There's still a chance that the biotech could have some good news on the way.